Cart
sales@molnova.com
Emtricitabine
CAS No. 143491-57-0
Emtricitabine ( BW-1592 )
Catalog No. M11849 CAS No. 143491-57-0
A nucleoside reverse transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 41 | In Stock |
|
| 100MG | 61 | In Stock |
|
| 500MG | 102 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEmtricitabine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA nucleoside reverse transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection.
-
DescriptionA nucleoside reverse transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection; also exhibits clinical activity against the hepatitis B virus (HBV).HIV Infection Approved
-
SynonymsBW-1592
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorReverseTranscriptase
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number143491-57-0
-
Formula Weight247.25
-
Molecular FormulaC8H10FN3O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10.8 mg/mL
-
SMILESC1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F
-
Chemical Name2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Saag MS. Clin Infect Dis. 2006 Jan 1;42(1):126-31.
2. Darque A, et al. Antimicrob Agents Chemother. 1999 Sep;43(9):2245-50.
3. Rousseau FS, et al. J Infect Dis. 2003 Dec 1;188(11):1652-8.
2. Darque A, et al. Antimicrob Agents Chemother. 1999 Sep;43(9):2245-50.
3. Rousseau FS, et al. J Infect Dis. 2003 Dec 1;188(11):1652-8.
molnova catalog
related products
-
Cys-TAT(47-57)
Cys-TAT(47-57) (Cys-[HIV-Tat (47-57)]) is an arginine rich cell penetrating peptide derived from the HIV-1 transactivating protein.This peptide corresponds to the protein transduction domain of the TAT protein.
-
BMS-818251
BMS-818251 (BMS818251) is a novel potent, small-molecule inhibitor of HIV-1 entry with EC50 of 0.019 nM against e laboratory-adapted HIV-1 strain NL4-3.
-
I-XW-053
I-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity.
